Unlocking Echocardiograms to Treat Undiagnosed Hypertension — The NOTIFY‑LVH Randomized Trial
Highlight
• A centralized population-health coordinator notification for patients with prior echocardiographic left ventricular hypertrophy (LVH) increased initiation of antihypertensive therapy (16.3% vs 5.0%; adjusted OR 3.76, 95% CI 2.09–6.75).
• The intervention also increased new hypertension diagnoses (adjusted OR 4.43, 95% CI 2.36–8.33) over 12 months; cardiomyopathy diagnoses were unchanged.
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.